<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kallmeyer A</submitter><funding>Instituto de Salud Carlos III FEDER</funding><funding>Ministry of Science and innovation</funding><funding>Instituto de Salud Carlos III (ISCIII)</funding><pagination>960</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9917543</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(3)</volume><pubmed_abstract>The pathophysiological mechanisms underlying Myocardial Infarction with Non-Obstructive Coronary Artery Disease (MINOCA) are still under debate. Lipoprotein (a) [Lp(a)] has proinflammatory and prothrombotic actions and has been involved in the pathogenesis of atherosclerosis. However, no previous studies have linked Lp(a) levels with the probability of developing MINOCA. Moreover, the relationship between MINOCA and the plasma levels of other proatherogenic and proinflammatory molecules such as Interleukin-18 (IL18) and proprotein convertase subtilisin/kexin type 9 (PCSK9) has not been studied. We conducted a prospective, multicenter study involving 1042 patients with acute myocardial infarction (AMI). Seventy-six patients had no significant coronary lesions. All patients underwent plasma </pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions.</pubmed_title><pmcid>PMC9917543</pmcid><funding_grant_id>RD09/0076/00101</funding_grant_id><funding_grant_id>PI22/00233</funding_grant_id><funding_grant_id>RTC2019-006826-1</funding_grant_id><funding_grant_id>PI17/01495</funding_grant_id><funding_grant_id>PI20/00923</funding_grant_id><funding_grant_id>PI19/00128</funding_grant_id><pubmed_authors>Gonzalez-Lorenzo O</pubmed_authors><pubmed_authors>Tunon J</pubmed_authors><pubmed_authors>Huelmos A</pubmed_authors><pubmed_authors>Lopez-Castillo M</pubmed_authors><pubmed_authors>Lorenzo O</pubmed_authors><pubmed_authors>Lumpuy-Castillo J</pubmed_authors><pubmed_authors>Lopez-Bescos L</pubmed_authors><pubmed_authors>Gutierrez-Landaluce C</pubmed_authors><pubmed_authors>Cristobal C</pubmed_authors><pubmed_authors>Acena A</pubmed_authors><pubmed_authors>Pello Lazaro AM</pubmed_authors><pubmed_authors>Tarin N</pubmed_authors><pubmed_authors>Kallmeyer A</pubmed_authors><pubmed_authors>Blanco-Colio LM</pubmed_authors><pubmed_authors>Alonso Martin JJ</pubmed_authors><pubmed_authors>Egido J</pubmed_authors><pubmed_authors>Montalvo JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions.</name><description>The pathophysiological mechanisms underlying Myocardial Infarction with Non-Obstructive Coronary Artery Disease (MINOCA) are still under debate. Lipoprotein (a) [Lp(a)] has proinflammatory and prothrombotic actions and has been involved in the pathogenesis of atherosclerosis. However, no previous studies have linked Lp(a) levels with the probability of developing MINOCA. Moreover, the relationship between MINOCA and the plasma levels of other proatherogenic and proinflammatory molecules such as Interleukin-18 (IL18) and proprotein convertase subtilisin/kexin type 9 (PCSK9) has not been studied. We conducted a prospective, multicenter study involving 1042 patients with acute myocardial infarction (AMI). Seventy-six patients had no significant coronary lesions. All patients underwent plasma </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-08-18T09:53:32.493Z</modification><creation>2025-08-18T09:53:32.493Z</creation></dates><accession>S-EPMC9917543</accession><cross_references><pubmed>36769608</pubmed><doi>10.3390/jcm12030960</doi></cross_references></HashMap>